A Contrast Frugal Approach to Transcatheter Aortic Valve Replacement in Chronic Kidney Disease: A Pilot Study
- PMID: 36699759
- PMCID: PMC9870599
- DOI: 10.7759/cureus.32878
A Contrast Frugal Approach to Transcatheter Aortic Valve Replacement in Chronic Kidney Disease: A Pilot Study
Abstract
Background: Transcatheter aortic valve replacement (TAVR) is now regarded as a viable treatment option for all cases of severe aortic stenosis (AS). Acute kidney injury (AKI) is common and lowers the survival of patients after TAVR and iodine-based contrast-induced nephropathy (CIN) plays a significant adverse role in AKI. Therefore, in chronic kidney disease (CKD) patients requiring pre-operative evaluation for TAVR, the risk of CIN is of particular concern.
Methods: It was a single-center study including eight CKD patients who underwent pre-operative evaluation for TAVR with minimized contrast exposure by means of pre-operative contrast-sparing evaluation and intra-operative contrast minimization. All patients had glomerular filtration rate (eGFR) calculated before TAVR and on a follow-up about one month and one year post-operatively to document the impact of this TAVR protocol on prognosis of kidney function in patients with advanced CKD.
Results: New York Heart Association (NYHA) functional classification demonstrated significant improvement of symptomatology (p = 0.0001) by one-year post-TAVR. Patients' mean AS gradient was significantly improved (p = 0.00004) after the TAVR procedure. No significant post-operative paravalvular aortic regurgitation was noted on follow up echocardiogram. eGFR data showed mean eGFR for the group was slightly better (27.38 ml/min/per 1.73 m2 BSA vs. 30.38 ml/min/per 1.73 m2 BSA) after TAVR.
Conclusions: "Contrast frugal" approach is feasible and safe for pre-TAVR evaluation and the procedure itself. Our pilot study showed no significant paravalvular leak of the prosthetic valve following this proposed protocol. No statistically significant decrease in eGFR was noted on a one-year follow-up.
Keywords: acute kidney injury; aortic stenosis; chronic kidney disease; contrast induced nephropathy; transcatheter aortic valve replacement.
Copyright © 2022, Bose et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Transfemoral transcatheter aortic valve replacement without contrast medium using the Medtronic CoreValve system: a single center experience.J Cardiovasc Surg (Torino). 2020 Aug;61(4):489-495. doi: 10.23736/S0021-9509.20.11083-8. Epub 2020 Apr 1. J Cardiovasc Surg (Torino). 2020. PMID: 32241088
-
Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve Replacement.JAMA Netw Open. 2021 Mar 1;4(3):e213296. doi: 10.1001/jamanetworkopen.2021.3296. JAMA Netw Open. 2021. PMID: 33769507 Free PMC article.
-
Renal function changes associated with transcatheter aortic valve-in-valve for prosthetic regurgitation compared to stenosis.Int J Cardiol Heart Vasc. 2022 Mar 14;39:100999. doi: 10.1016/j.ijcha.2022.100999. eCollection 2022 Apr. Int J Cardiol Heart Vasc. 2022. PMID: 35310374 Free PMC article.
-
Transcatheter Aortic Valve Replacement: a Kidney's Perspective.J Renal Inj Prev. 2016 Jan 18;5(1):1-7. doi: 10.15171/jrip.2016.01. eCollection 2016. J Renal Inj Prev. 2016. PMID: 27069960 Free PMC article. Review.
-
Impact of Pre-existing Kidney Dysfunction on Outcomes Following Transcatheter Aortic Valve Replacement.Curr Cardiol Rev. 2017;13(4):283-292. doi: 10.2174/1573403X13666170804151608. Curr Cardiol Rev. 2017. PMID: 28782492 Free PMC article. Review.
Cited by
-
Transcatheter aortic valve replacement in patients with chronic kidney disease: a multi-centre retrospective study.Ann Med Surg (Lond). 2023 Dec 5;86(2):697-702. doi: 10.1097/MS9.0000000000001590. eCollection 2024 Feb. Ann Med Surg (Lond). 2023. PMID: 38333245 Free PMC article.
References
-
- FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery | FDA. [ Sep; 2022 ]. 2019. https://www.fda.gov/news-events/press-announcements/fda-expands-indicati... https://www.fda.gov/news-events/press-announcements/fda-expands-indicati...
-
- Acute kidney injury after transcatheter aortic valve replacement: a systematic review and meta-analysis. Thongprayoon C, Cheungpasitporn W, Srivali N, Ungprasert P, Kittanamongkolchai W, Greason KL, Kashani KB. Am J Nephrol. 2015;41:372–382. - PubMed
-
- Epidemiology of acquired valvular heart disease. Iung B, Vahanian A. Can J Cardiol. 2014;30:962–970. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous